Gary J. Nabel insider trades
Open-market stock purchases and sales by Gary J. Nabel, Unknown at Candel Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2021.
Track record: 12% of 26 scored buys are up 5% or more since purchase, averaging -20%.